Table 1 Characteristics of included studies on tumor location and UTUC

From: The impact of tumor location and multifocality on prognosis for patients with upper tract urothelial carcinoma: a meta-analysis

Study

Location

Study period

No. of participants

Tumor location and No. of cases

Median age (range), yr

Study qualitya

Adjusted variables

Raman 2009

globe

1987–2007

1249

U:426

68(27–97)

8

age, gender, surgical approach (open vs laparoscopic), prior endoscopic therapy, pT stage, grade, lymph node status

P:823

Yafi 2011

globe

1990–2010

673

U:215

68(61–75)

8

age, gender, race, presence of lymphovascular invasion, concomitant carcinoma in situ, pathological stage, lymph node dissection and type of surgery (open vs laparoscopic)

P:376

M:46

Novara 2007

Europe

1989–2005

269

U:92

67.7

8

age, gender, history of previous bladder cancer, synchronous muscle-invasive bladder TCC, pT stage, tumor grade, lymph nodes, presence of lymphatic and/or vascular invasion, surgical margin status, tumor site

P:101

M:113

Isbarn 2009

USA

1988–2004

2824

U:911

NR

8

age, race, region, gender, types of surgery, pT stage, pN stage, tumor grade and year of surgery quartiles

P:1913

Kobayashi 2010

Japan

2000–2004

221

U:111

72(46–92)

8

age, sex, pT stage, tumor grade, venous invasion, lymphatic invasion, surgical techniques

P:110

Dragicevic 2007

Serbia

1998–2005

114

U:30

67(38–86)

7

age, sex, BEN or non-endemic area of residence, serum, creatinine levels, Hb, synchronous bladder tumor, tumor size, tumor grade, tumor stage and lymphovascular invasion

P:37

M:36

Favaretto 2010

USA

1995–2008

253

U:78

72(64–77)

8

age, gender, race, smoking history, previous non-muscle-invasive bladder tumor, pT stage, pN stage, tumor grade, concomitant carcinoma in situ

P:171

Akdogan 2005

Turkey

1987–2003

72

U:21

58.9

8

age, sex, T stage, grade, bladder tumor history

P:51

Park 2004

Korea

1991–2001

86

U:41

59.5

9

age, grade, T stage, N stage, grade,

P:45

Chromecki 2011

globe

1987–2007

2492

U:640

69.2(54.1–84.2)

8

age, gender, T stage, N stage, tumor stage, tumor architecture, lymphovascular invasion, lymph node involvement, receiving adjuvant chemotherapy

P:1262

M:590

Lehmann 2006

Germany

1975–2004

145

U:136

68(29–85)

8

age, sex, pT stage, tumor grade, N stage, tumor stage, treatinin, alkaline phosphatase, WBC count, blood urea nitrogen, platelet count

M:19

Milojevic 2011

Serbia

1999–2009

133

U:45

NR

7

age, sex, laterality, previous carcinoma not invading bladder muscle, tumor grade, tumor stage, N stage, lymphovascular invasion

P:88

Ouzzane 2011

France

1995–2010

609

U:185

70(62–76)

8

age, sex, pT stage, tumor grade, N stage, lymphovascular invasion,

P:317

M:107

Zhang 2012

China

2000–2010

217

U:71

69(62–81)

8

gender, age, tumor stage, tumor grade, lymphovascular invasion, and lymph node status, preoperative hydronephrosis, type of surgery, follow-up

P:146

Park 2009

Korea

1991–2005

224

U:102

63

9

age, sex, T stage, N stage, grade, adjuvant chemotherapy

P:122

Mouracade 2011

Canada

1985–2005

269

U:108

66.7

8

age, gender, pT stage, pN stage, tumor grade, surgical margin status, adjuvant chemotherapy, period of diagnosis

P:161

Cha 2012

globe

1987–2007

2244

U:795

69.9

9

age, gender, pT stage, pN stage, tumor grade, lymphovascular invasion, sessile tumor architecture, concomitant CIS, previous bladder cancer

P:1449

  1. Abbreviation: M, multifocal; NR, not reported; P, pelvis; U, ureter.
  2. a: Study quality was judged on the basis of the Newcastle-Ottawa Scale (1–9 stars).